Morphologic and molecular genetic aspects of oligodendroglial neoplasms

Neuro-Oncology

Volumn 1, Issue 1, 1999, Pages 52-60

  Bigner, Sandra H ^a   Rasheed, B K Ahmed ^a   Wiltshire, Rodney ^a   McLendon, Roger E ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16INK4A; PROTEIN P53;

ASTROCYTOMA; BRAIN TUMOR; CLASSIFICATION; COMPARATIVE STUDY; GENETICS; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CHROMOSOME; KARYOTYPING; NUCLEIC ACID HYBRIDIZATION; OLIGODENDROGLIOMA; PATHOLOGY; PHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE; ULTRASTRUCTURE; WORLD HEALTH ORGANIZATION;

ASTROCYTOMA; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENES, P16; GENES, P53; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; KARYOTYPING; LOSS OF HETEROZYGOSITY; NUCLEIC ACID HYBRIDIZATION; OLIGODENDROGLIOMA; TUMOR SUPPRESSOR PROTEIN P53; WORLD HEALTH ORGANIZATION;

EID: 0032601042     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1093/neuonc/1.1.52     Document Type: Article

References (50)

1. Bailey, P., and Bucy, P.C. (1929) Oligodendrogliomas of the brain. J. Pathol. Baderiol. 32, 735-751.
2. Bailey, P., and Cushing, H.A. (1926) A classification of the gliomata. In:Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis. Philadelphia: Lippincott. pp. 53-95.
3. Bardosi, A., Dimitri, T., and Gabius, H.J. (1988) Endogenous carbohydrate-binding proteins in oligodendrogliomas. A histochemical study. Acta. Neuropathol. 76, 55-61.
4. Bello, M.J., Vaquero, J., de Campos, J.M., Kusak, M.E., Sarasa, J.L., Saez, J., Pestafia, A., Rey, J.A. (1994) Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1 p in oligodendroglial tumors. Intl. J. Cancer 57, 172-175.
5. Bello, M.J., Leone, P.E., Nebreda, P., de Campos, J.M., Kusak, M.E., Vaquero, J., Sarasa, J.L., Garcia-Miguel, P., Queizan, A., Hernández-Moneo, J.L., Pestana, A., and Rey, J.A. (1995) Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet. Cytogenet. 83, 160-164.
6. Bruner, J.M. (1987) Oligodendroglioma: Diagnosis and prognosis. Semin. Diagn. Pathol. 4, 251-261.
7. Burger, P.C., Rawlings, C.E., Cox, E.B., McLendon, R.E., Schold, S.C., Jr., and Bullard, D.E. (1987) Clinicopathologic correlations in the oligodendroglioma. Cancer 59, 1345-1352.
8. Cairncross, J.G., Ueki, K., Zlatescu, M.C., Lisle, D.K., Finkelstein, D.M., Hammond, R.R., Silver, J.S., Stark, P.C., Macdonald, D.R., Ino, Y., Ramsay, D.A., and Louis, D.N. (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogiomas. J. Natl. Cancer Inst. 90, 1473-1479.
9. Choi, B.H., and Kim, R.C. (1984) Expression of glial fibrillary acidic protein in immature oligodendroglia. Science 223, 407-409.
10. Choi, B.H., and Lapham, L.W. (1978) Radial glia in the human fetal cerebrum: A combined golgi, immunofluorescent and electron microscopic study. Brain Res. 148, 295-311.
11. Choi, B.H., Kim, R.C., and Lapham, L.W. (1983) Do radial glia give rise to both astroglial and oligodendroglial cells? Brain Res. 284, 119-135.
12. Coons, S.W., Johnson, P.C., and Pearl, D.K. (1997) The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery 41, 878-885.
13. Cruz-Sanchez, F.F., Rossi, M.L., Buller, J.R., Carboni, P., Jr., Fineron, P.W., and Coakham, H.B. (1991) Oligodendrogliomas: A clinical, histological, immunocytochemical and lectin-binding study. Histopathology 19, 361-367.
14. Daumas-Duport, C., Monsaigneon, V., Blond, S., Munari, C., Musolino, A., Chodkiewicz, J.P., and Missir, O. (1987) Serial stereotactic biopsies and CT scan in gliomas: Correlative study in 100 astrocytomas, oligoastrocytomas and oligodendrocytomas. J. Neurooncol. 4, 317-328.
15. Dehghani, J., Schachenmayr, W., Laun, A., and Korf, H. (1998) Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: A study of 89 cases. Acta. Neuropathol. 96, 493-504.
16. Earnest, F., III, Kernohan, J.W., and Craig, W.M. (1950) Oligodendrogliomas. Review of 200 cases. Arch. Neurol. Psychiatry 63, 964-976.
17. Kimura, T., Budka, H., and Soler-Federsppiel, S. (1986) An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumours. Clin. Neuropathol. 5, 21-27.
18. Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993) Histological Typing of Tumours of the Central Nervous System, 2nd edition. New York: Springer-Verlag, pp. 1-105.
19. Kraus, J.A., Koopmann, J., Kaskel, P., Maintz, D., Brandner, S., Schramm, J., Louis, D.N., Wiestler, O.D., and von Deimling, A. (1995) Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J. Neuropathol. Exp. Neurol. 54, 91-95.
20. Kros, J.M., Van Eden, C.G., Stefanko, S.Z., Waayer-Van Batenburg, M., and van der Kwast, T.H. (1990) Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas. Cancer 66, 1204-1212.
21. Kros, J.M., de Jong, A.A.W., and van der Kwast, T.H. (1992) Ultrastructural characterization of transitional cells in oligodendrogliomas. J. Neuropathol. Exp. Neurol. 51, 185-193.
22. Kros, J.M., Hop, W.C., Godschalk, J.J.C.I., and Krishmadath, K.K. (1996) Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas. Cancer 78, 1107-1113.
23. Maintz, D., Fiedler, K., Koopmann, J., Rollbrocker, B., Nechev, S., Lenartz, D., Stangl, A.P., Louis, D.N., Schramm, J., Wiestler, O.D., and von Deimling, A. (1997) Molecular genetic evidence for subtypes of oligoastrocytomas. J. Neuropathol. Exp. Neurol. 56, 1098-1104.
24. Matthews, M.R., Rasheed, B.K.A., McLendon, M.E., Wikstrand, C.J., Bigner, D.D., and Bigner, S.H. (1998) Molecular and immunohistologic (IHC) studies on oligodendroglial (O) tumors. J. Neuropathol. Exp. Neurol. 57, 473. (Abstract)
25. Mørk, S.J., Lindegaard, K.-F., Halvorsen, T.B., Lehmann, E.H., Solgaard, T., Hatlevoli, R., Harvei, S., and Ganz, J. (1985) Oligodendroglioma: Incidence and biological behavior in a defined population. J. Neurosurg. 63, 881-889.
26. Mørk, S.J., Halvorsen, T.B., Lindegaard, K.-F., and Eide, G.E. (1986) Oligodendroglioma. Histologic evaluation and prognosis. J. Neuropathol. Exp. Neurol. 45, 65-78.
27. Nakagawa, Y., Perentes, E., and Rubinstein, L.J. (1986) Immunohistochemical characterization of oligodendrogliomas: An analysis of multiple markers. Acta. Neuropathol. 72, 15-22.
28. Nakagawa, Y., Perentes, E., and Rubinstein, L.J. (1987) Non-specificity of anti-carbonic anhydrase C antibody as a marker in human neurooncology. J. Neuropathol. Exp. Neurol. 46, 451-460.
29. Nakamura, Y., Becker, L.E., and Marks, A. (1983) Distribution of immunoreactive S-100 protein in pediatric brain tumors. J. Neuropathol. Exp. Neurol. 42, 136-145.
30. Nakopoulou, L., Kerezoudi, E., Thomaides, T., and Litsios, B. (1990) An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors. J. Neurooncol. 8, 33-40.
31. Ng, H.K., Ko, H.C.W., and Tse C.C.H (1994) Immunohistochemical and ultrastructural studies of oligodendrogliomas revealed features of neuronal differentiation. Int. J. Surg. Pathol. 2, 47-56.
32. Nishizaki, T., Ozaki, S., Harada, K., Ito, H., Arai, H., Beppu, T., and Sasaki, K. (1998) Investigation of genetic alterations associated with the grade of Astrocytic Tumor by comparative genomic hybridization. Genes Chromosomes Cancer 21, 340-346.
33. Ogawa, H., Sato, Y., Takeshita, I., Tateishi, J., and Kitamura, K. (1985) Transient expression of glial fibrillary acidic protein in developing oligodendrocytes in vitro. Brain Res. 350, 133-141.
34. Perentes, E., and Rubinstein, L.J. (1986) Immunohistochemical recognition of human neuroepithelial tumours by anti-Leu 7 (HNK-I) monoclonal antibody. Acta. Neuropathol. 69, 227-233.
35. Raff, M.C., Abney, E.A., and Fok-Seang, J. (1985) Reconsitution of a developmental clock in vitro, a critical role for astrocytes in the timing of oligodendrocyte differentiation. Cell 42, 61-69.
36. Ransom, D.T., Ritland, S.R., Jenkins, R.B., Scheithauer, B., Kelly, P.J., and Kimmel, D.W. (1991) Loss of heterozygosity studies in human gliomas. Proc. Am. Assoc. Cancer Res. 32, 302. (Abstract)
37. Reifenberger, J., Reifenberger, G., Liu, L., James, C.D., Wechsler, W., and Collins, V.P. (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am. J. Pathol. 145, 1175-1190.
38. Ritland, S.R., Ganju, V., and Jenkins, R.B. (1995) Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosomes Cancer 12, 277-282.
39. Rosenberg, J.E., Lisle, D.K., Burwick, J.A., Ueki, K., von Deimling, A., Mohrenweiser, H.W., and Louis, D.N. (1996) Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene 13, 2483-2485. (Short report)
40. Rosso, S.M., van Dekken, H., Krishnadath, K.K., Alers, J.C., and Kros, J.M. (1997) Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas. J. Neuropathol. Exp. Neurol. 56, 1125-1131.
41. Schiffer, D., Dutto, A., Cavalla, P., Chio, A., Micheli, A., and Piva, R. (1997) Role of apoptosis in the prognosis of oligodendrogliomas. Neurochem. Int. 31, 245-250.
42. Shaw, E.G., Scheithauer, B.W., O'Fallon, J.R., Tazelaar, H.D., and Davis, D.H. (1992) Oligodendrogliomas: The Mayo Clinic experience. J. Neurosurg. 76, 428-434.
43. Shaw, E.G., Scheithauer, B.W., O'Fallon, J.R., and Davis, D.H. (1994) Mixed oligoastrocytomas: A survival and prognostic factor analysis. Neurosurgery 34, 577-582.
44. Smith, M.T., Ludwig, C.T., Godfrey, A.D., and Ambrustmacher, V.W. (1983) Grading of oligodendrogliomas. Cancer 52, 2107-2114.
45. von Deimling, A., Louis, D.N., von Ammon, K., Petersen, I., Weistler, O.D., and Seizinger, B.R. (1992) Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res. 52, 4277-4279.
46. von Deimling, A., Nagel, J., Bender, B., Lenartz, D., Schramm, J., Louis, D.N., and Weistler, O.D. (1994) Deletion mapping of chromosome 19 in human gliomas. Int J. Cancer 57, 676-680.
47. Wharton, S.B., Hamilton, F.A., Chan, W.K., Chan, K.K., and Anderson, J.R. (1998) Proliferation and cell death in oligodendrogliomas. Neuropathol. Appl. Neurobiol. 24, 21-28.
48. Weber, R.G., Sabel, M., Reifenberger, J., Sommer, C., Oberstrab, J., Reifenberger, G., Kiessling, M., and Cremer, T. (1996) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13, 983-994.
49. Yong, W.H., Chou, D., Ueki, K., Harsh, G.R., von Deimling, A., Gusella, J.F., Mohrenweiser, H.W., and Louis, D.N. (1995) Chromosome 19q deletions in human gliomas overlap to D19S219 and may target a 425 kb region centromeric to D19S112. J. Neuropathol. Exp. Neurol. 54, 622-626.
50. Zhu, J.J., Santarius, T., Wu, X., Tsong, J., Guha, A., Wu, J.K., Hudson, T.J., and Black, P.M. (1998) Screening for loss of heterozygosity and micorsatellite instability in oligodendrogliomas. Genes Chromosomes Cancer 21, 207-216.